drugset / Trial / NCT00440401
TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)
RandomizedParallel-groupOpen-labelTreatment
Summary
To demonstrate efficacy and safety of TachoSil® in cardiovascular surgery
Timeline
- Start
- 2007-02
- Primary completion
- 2007-08
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fibrinogen Concentrate Human | Protein / enzyme biologic | — | — |
| Comparator | thrombin (human) | Unknown | — | — |